Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 10,789 | 9,626 | 9,419 | 7,357 | 6,845 |
| Gross Profit | 10,789 | 9,626 | 9,419 | 7,357 | 6,845 |
| Operating Expenses | 21,672 | 20,719 | 19,360 | 18,889 | 17,801 |
| Operating Income | -10,883 | -11,093 | -9,941 | -11,532 | -10,956 |
| Other Income | 1,687 | 895 | 1,123 | 1,121 | 1,343 |
| Pre-tax Income | -9,196 | -10,198 | -8,818 | -10,411 | -9,613 |
| Income Tax | N/A | N/A | N/A | -76 | N/A |
| Net Income Continuous | -9,196 | -10,198 | -8,818 | -10,335 | -9,613 |
| Net Income | $-9,196 | $-10,198 | $-8,818 | $-10,335 | $-9,613 |
| EPS Basic Total Ops | -0.72 | -1.33 | -1.17 | -1.54 | -1.51 |
| EPS Basic Continuous Ops | -0.72 | -1.33 | -1.17 | -1.55 | -1.51 |
| EPS Diluted Total Ops | -0.72 | -1.33 | -1.17 | -1.54 | -1.51 |
| EPS Diluted Continuous Ops | -0.72 | -1.33 | -1.17 | -1.55 | -1.51 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.33 | -1.17 | -1.57 | -1.51 |
| EBITDA(a) | $-11,482 | $-11,440 | $-10,416 | $-12,093 | $-11,764 |